(Q51990144)

English

Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment.

scientific article published on 22 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Kouzaburo Yamaji

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Shigeki Nabeshima

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Masayuki Murata

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Yong Chong

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Norihiro Furusyo

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Hideyuki Ikematsu

6

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Jun Hayashi

7

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

publication date

22 July 2005

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

55

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

394-403

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

https://scigraph.springernature.com/pub.10.1007/s00262-005-0005-x

0 references

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-005-0005-X

21 January 2018

IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs

1 reference

https://api.crossref.org/works/10.1007%2FS00262-005-0005-X

21 January 2018

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-005-0005-X

21 January 2018

Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00262-005-0005-X

21 January 2018

Identifiers

10.1007/S00262-005-0005-X

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16041541

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51990144&oldid=1540653972"